Journal of Affective Disorders
Volume 88, Issue 1 , Pages 27-45 , September 2005

A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia

Received 5 November 2004 ,Revised 4 April 2005 ,Accepted 9 May 2005.

References 

  1. Angenendt J, Frommberger U, Berger M. Zum Stellenwert psychotherapeutisch-pharmakologischer Kombinationstherapien bei Angststörungen. Verhaltenstherapie. 1998;8:160–169
  2. Bakker A, Spinhoven P, van Balkom AJLM, Matser D, van Dyck R. Double-blindness procedure did not mask giving of medication in panic disorder. Journal of Affective Disorders. 1999;54:189–192
  3. Bakker A, van Balkom AJLM, Spinhoven P. SSRIs vs. TCas in the treatment of panic disorder: a meta-analysis. Acta Psychiatrica Scandinavica. 2002;106:163–167
  4. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychological Review. 1977;84:191–215
  5. Basoglu M, Marks I, Livanou M, Swinson R. Double-blindness procedures, rater blindness, and ratings of outcome. Observations from a controlled trial. Archives of General Psychiatry. 1997;54:744–748
  6. Beck AT, Clark DA. An information processing model of anxiety: automatic and strategic processes. Behaviour Research and Therapy. 1996;35:49–58
  7. Becker BJ. Synthesizing standardized mean-change measures. British Journal of Mathematical & Statistical Psychology. 1988;41:257–278
  8. Begg CB. Publication Bias. In:  Cooper H,  Hedges LV editor. The Handbook of Research Synthesis. New York: Russell Sage Foundation; 1994;p. 399–410
  9. Black DW, Wesner RB, Gabel J, Bowers W, Monahan P. Predictors of short-term response in 66 patients with panic disorder. Journal of Affective Disorders. 1994;30:233–241
  10. Boyer W. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. International Clinical Psychopharmacology. 1995;10:45–49
  11. Brown TA, Barlow DH. Classification of anxiety and mood disorder. In:  Barlow DH editors. Anxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic. 2nd ed.. New York: The Guilford Press; 2002;p. 292–327
  12. Chambless DL, Gillis MM. Cognitive therapy of anxiety disorders. Journal of Consulting and Clinical Psychology. 1993;61:248–260
  13. Clark DM. A cognitive approach to panic. Behaviour Research and Therapy. 1986;24:461–470
  14. Clum GA. Coping with Panic. Pacific Grove: Brooks/Cole Publishing; 1990;
  15. Clum GA, Clum GA, Surls R. A meta-analysis of treatments for panic disorder. Journal of Consulting and Clinical Psychology. 1993;61:317–326
  16. Coplan JD, Lydiard RB. Brain circuits in panic disorder. Biological Psychiatry. 1998;44:1264–1276
  17. Craske MG. An integrated treatment approach to panic disorder. Bulletin of the Menninger Clinic. 1996;60(Suppl. A):A87–A104
  18. Davey GCL. Classical conditioning and the acquisition of human fears and phobias: a review and synthesis of the literature. Advances in Behaviour Research and Therapy. 1992;14:29–66
  19. Duval S, Tweedie R. Trim and fill: a simple funnel plot based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;50:455–463
  20. Gelder MG, Marks IM. Severe agoraphobia: a controlled prospective trial of behavior therapy. British Journal of Psychiatry. 1966;112:309–319
  21. Gleser LJ, Olkin I. Stochastically dependent effect sizes. In:  Cooper H,  Hedges LV editor. The Handbook of Research Synthesis. New York: Russell Sage Foundation; 1994;p. 340–355
  22. Goddard AW, Charney DS. Toward an integrated neurobiology of panic disorder. Journal of Clinical Psychiatry. 1997;58(Suppl. 2):4–12
  23. Gorman JM, Kent JM, Sullivan GM, Coplan JD. Neuroanatomical hypothesis of panic disorder, revised. American Journal of Psychiatry. 2000;157:493–505
  24. Gould RA, Otto MW, Pollack MH. A meta-analysis of treatment outcome for panic disorder. Clinical Psychology Review. 1995;15:819–844
  25. Haddock CK, Rindskopf D, Shadish WR. Using odds ratio as effect sizes for meta-analysis of dichotomous data: a primer on methods and issues. Psychological Methods. 1998;3:339–353
  26. Hansson L. Quality of life in depression and anxiety. International Review of Psychiatry. 2002;14:185–189
  27. Hedges LV, Olkin I. Statistical Methods for Meta-Analysis. Orlando, FL: Academic Press; 1985;
  28. Hedges LV, Vevea JL. Fixed- and random-effects models in meta-analysis. Psychological Methods. 1998;3:486–504
  29. Hollister LE, Muller-Oerlinghausen B, Rickels K, Shader RI. Clinical uses of benzodiazepines. Journal of Clinical Psychopharmacology. 1993;13:1S–169S
  30. Hunter JE, Schmidt FL. Methods of Meta-Analysis. Newbury Park: Sage; 1990;
  31. Katon W. Panic disorder: relationship to high medical utilization, unexplained physical symptoms, and medical costs. Journal of Clinical Psychiatry. 1996;57(Suppl. 10):11–18
  32. Keller MB, Yonkers KA, Warshaw MG, Pratt LA, Golan J, Mathews AO, et al. Remission and relapse in subjects with panic disorder and panic with agoraphobia: a prospective short interval naturalistic follow-up. Journal of Nervous and Mental Disorders. 1994;182:290–296
  33. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. British Journal of Psychiatry. 1994;168:17–30
  34. Kirsch, I., Sapirstein, G., 1998. Listening to prozac but hearing placebo: a meta-analysis of antidepressant medication. Prevention and Treatment, 1, Artikel 0002a, http://journals.apa.org/prevention/volume1/pre0010002a.html.
  35. Klerman GL, Weissman MM, Oullette R, Johnson J, Greenwald S. Panic attacks in the community: social morbidity and health care utilization. JAMA. 1991;265:742–746
  36. Lochner C, Mogotsi M, du Toit PL, Kaminer D, Niehaus DJ, Stein DJ. Quality of life in anxiety disorders: a comparison of obsessive–compulsive disorder, social anxiety disorder, and panic disorder. Psychopathology. 2003;36:255–262
  37. Margraf J, Ehlers E, Roth WT, Clark DB, Sheikh J, Agras WS, et al. How .blind. are double-blind studies?. Journal of Consulting and Clinical Psychology. 1991;59:184–187
  38. Marks I. Agoraphobia and Panic Disorder. Oxford: John Wiley & Sons; 1989;
  39. Marks I, Dar R. Fear reductions by psychotherapies. Recent findings, future directions. British Journal of Psychiatry. 2000;176:507–511
  40. Matt GE, Navarro AM. What meta-analyses have and have not taught us about psychotherapy effects: a review and future directions. Clinical Psychology Review. 1997;17:1–32
  41. Mendlowicz MV, Stein MB. Quality of life in individuals with anxiety disorders. American Journal of Psychiatry. 2000;157:669–682
  42. Mitte, K., in press. A meta-analysis of cognitive behavioral treatments for generalized anxiety disorder. A comparison with pharmacotherapy. Psychological Bulletin.
  43. Oei TPS, Llamas M, Devilly GJ. The efficacy and cognitive processes of cognitive behaviour therapy in the treatment of panic disorder with agoraphobia. Behavioural and Cognitive Psychotherapy. 1999;27:63–88
  44. Ray JW, Shadish WR. How interchangeable are different estimators of effect size?. Journal of Consulting and Clinical Psychology. 1996;64:1316–1325
  45. Ruhmland M, Margraf J. Effektivität psychologischer Therapien von Panik und Agoraphobie: Meta-Analysen auf Störungsebene. Verhaltenstherapie. 2001;11:41–53
  46. Shadish WR, Haddock CK. Combining estimates of effect size. In:  Cooper H,  Hedges LV editor. The handbook of research synthesis. New York: Russel Sage Foundation; 1994;p. 261–281
  47. Siegel L, Jones WC, Wilson JO. Economic and life consequences experienced by a group of individuals with panic disorder. Journal of Anxiety Disorders. 1990;4:201–211
  48. Van Balkom AJLM, Bakker A, Spinhoven P, Blaauw BMJW, Smeenk S, Ruesink B. A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive behavioral, and combination treatments. Journal of Nervous and Mental Disease. 1997;185:510–516
  49. Westen D, Morrison K. A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies. Journal of Consulting and Clinical Psychology. 2001;69:875–899
  50. Westra HA, Stewart SH. Cognitive behavioural therapy and pharmacotherapy: complementary or contradictory approaches to the treatment of anxiety?. Clinical Psychology Review. 1998;18:307–340
  51. White KS, Barlow DH. Panic disorder and agoraphobia. In:  Barlow DH editors. Anxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic. 2nd ed.. New York: The Guilford Press; 2002;p. 328–379
  52. Woods JH, Katz JL, Winger G. Benzodiazepines: use, abuse, and consequences. Pharmacological Review. 1992;44:151–347
  53. Yonkers KA, Zlotnick C, Allsworth J, Warshaw M, Shea T, Keller MB. Is the course of panic disorder the same in women and men?. American Journal of Psychiatry. 1998;155:596–602

PII: S0165-0327(05)00127-8

doi: 10.1016/j.jad.2005.05.003

Journal of Affective Disorders
Volume 88, Issue 1 , Pages 27-45 , September 2005

Article Tools